2.Re-detectable positive SARS-CoV-2 RNA tests in patients who recovered from COVID-19 with intestinal infection.
Wanyin TAO ; Xiaofang WANG ; Guorong ZHANG ; Meng GUO ; Huan MA ; Dan ZHAO ; Yong SUN ; Jun HE ; Lianxin LIU ; Kaiguang ZHANG ; Yucai WANG ; Jianping WENG ; Xiaoling MA ; Tengchuan JIN ; Shu ZHU
Protein & Cell 2021;12(3):230-235
3.Positive RT-PCR detected in patients recovered from COVID-19.
Glorijoy Shi En TAN ; Ying DING ; Lin CUI ; Tze Minn MAK ; Chee Keng MOK ; Asok KURUP ; Purnima PARTHASARATHY ; Wan Ni CHIA ; Lin Fa WANG ; Raymond T P LIN ; Yee Sin LEO ; Shawn VASOO
Annals of the Academy of Medicine, Singapore 2021;50(2):191-194
4.Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody.
Fang LI ; Meng LUO ; Wenyang ZHOU ; Jinliang LI ; Xiyun JIN ; Zhaochun XU ; Liran JUAN ; Zheng ZHANG ; Yuou LI ; Renqiang LIU ; Yiqun LI ; Chang XU ; Kexin MA ; Huimin CAO ; Jingwei WANG ; Pingping WANG ; Zhigao BU ; Qinghua JIANG
Protein & Cell 2021;12(10):751-755
5.High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
Yao ZHAO ; Xiaoyu DU ; Yinkai DUAN ; Xiaoyan PAN ; Yifang SUN ; Tian YOU ; Lin HAN ; Zhenming JIN ; Weijuan SHANG ; Jing YU ; Hangtian GUO ; Qianying LIU ; Yan WU ; Chao PENG ; Jun WANG ; Chenghao ZHU ; Xiuna YANG ; Kailin YANG ; Ying LEI ; Luke W GUDDAT ; Wenqing XU ; Gengfu XIAO ; Lei SUN ; Leike ZHANG ; Zihe RAO ; Haitao YANG
Protein & Cell 2021;12(11):877-888
A new coronavirus (SARS-CoV-2) has been identified as the etiologic agent for the COVID-19 outbreak. Currently, effective treatment options remain very limited for this disease; therefore, there is an urgent need to identify new anti-COVID-19 agents. In this study, we screened over 6,000 compounds that included approved drugs, drug candidates in clinical trials, and pharmacologically active compounds to identify leads that target the SARS-CoV-2 papain-like protease (PLpro). Together with main protease (M
Antiviral Agents/therapeutic use*
;
Binding Sites
;
COVID-19/virology*
;
Coronavirus Papain-Like Proteases/metabolism*
;
Crystallography, X-Ray
;
Drug Evaluation, Preclinical
;
Drug Repositioning
;
High-Throughput Screening Assays/methods*
;
Humans
;
Imidazoles/therapeutic use*
;
Inhibitory Concentration 50
;
Molecular Dynamics Simulation
;
Mutagenesis, Site-Directed
;
Naphthoquinones/therapeutic use*
;
Protease Inhibitors/therapeutic use*
;
Protein Structure, Tertiary
;
Recombinant Proteins/isolation & purification*
;
SARS-CoV-2/isolation & purification*
6.Clinical manifestations and pathogen characteristics in children admitted for suspected COVID-19.
Xiaofang CAI ; Hanlan JIANG ; Simin ZHANG ; Shengying XIA ; Wenhui DU ; Yaoling MA ; Tao YU ; Wenbin LI
Frontiers of Medicine 2020;14(6):776-785
Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has spread around the world. However, approaches to distinguish COVID-19 from pneumonia caused by other pathogens have not yet been reported. We retrospectively analyzed the clinical data of 97 children with probable COVID-19. A total of 13 (13.4%) patients were confirmed positive for SARS-CoV-2 infection by nucleic acid RT-PCR testing, and 41 (42.3%) patients were found to be infected with other pathogens. Notably, no pathogen was detected in 43 (44.3%) patients. Among all patients, 25 (25.8%) had familial cluster exposure history, and 52 (53.6%) had one or more coexisting conditions. Fifteen (15.5%) patients were admitted or transferred to the PICU. In the 11 confirmed COVID-19 cases, 5 (45.5%) and 7 (63.6%) were positive for IgM and IgG against SARS-CoV-2, respectively. In 22 patients with suspected COVID-19, 1 (4.5%) was positive for IgG but negative for IgM. The most frequently detected pathogen was Mycoplasma pneumonia (29, 29.9%). One patient with confirmed COVID-19 died. Our results strongly indicated that the detection of asymptomatic COVID-19 or coexisting conditions must be strengthened in pediatric patients. These cases may be difficult to diagnose as COVID-19 unless etiologic analysis is conducted. A serologic test can be a useful adjunctive diagnostic tool in cases where SARS-CoV-2 infection is highly suspected but the nucleic acid test is negative.
Age Factors
;
COVID-19/diagnosis*
;
COVID-19 Testing
;
Child
;
Child, Preschool
;
China
;
Female
;
Hospitalization
;
Humans
;
Infant
;
Male
;
Retrospective Studies
;
SARS-CoV-2/isolation & purification*
;
Symptom Assessment
7.TTSH and NCID Radiology Services in COVID-19.
Hsien Min LOW ; Eugene LOW ; Chau Hung LEE
Annals of the Academy of Medicine, Singapore 2020;49(11):913-914
Academic Medical Centers
;
COVID-19/prevention & control*
;
Cross Infection/prevention & control*
;
Disinfection
;
Hospitals, Isolation
;
Humans
;
Infection Control/methods*
;
Infectious Disease Transmission, Patient-to-Professional/prevention & control*
;
Radiology
;
Radiology Department, Hospital/organization & administration*
;
SARS-CoV-2
;
Singapore
8.Deployment of a Forward Medical Post to Provide Medical Support in a Purpose-built Dormitory during the COVID-19 Pandemic.
Guan Lin LEE ; Wei Ting LEE ; Wai Leong KOK
Annals of the Academy of Medicine, Singapore 2020;49(11):928-930
COVID-19/therapy*
;
COVID-19 Testing
;
Communicable Disease Control
;
Early Diagnosis
;
Housing
;
Humans
;
Infection Control/organization & administration*
;
Patient Isolation
;
Primary Health Care/organization & administration*
;
Residence Characteristics
;
SARS-CoV-2
;
Singapore
;
Transients and Migrants
9.Environmental Monitoring of A Laboratory for New Coronavirus Nucleic Acid Testing.
Pei Yong NING ; Ai Ping YU ; Yuan WANG ; Li Ru GUO ; Dan SHAN ; Mei KONG ; Ling Qi YU ; Li Kun LYU ; Ming ZOU ; Xu SU ; Chun Nan FEI ; Yu Hui ZHOU ; Bai Qi WANG
Biomedical and Environmental Sciences 2020;33(10):771-774
10.Pulmonary Nodules Developed Rapidly in Staffs in the Isolation Ward of a Chinese Hospital during the COVID-19 Epidemic.
Yu Hua LI ; Ke Wen YU ; Neng Jun SUN ; Xiao Dong JIN ; Xin LUO ; Jing YANG ; Bing HE ; Bo LI
Biomedical and Environmental Sciences 2020;33(12):930-934
Adult
;
COVID-19/virology*
;
China
;
Cross Infection/virology*
;
Epidemics
;
Female
;
Health Personnel/statistics & numerical data*
;
Hospitals/statistics & numerical data*
;
Hospitals, Isolation/statistics & numerical data*
;
Humans
;
Male
;
Multiple Pulmonary Nodules/diagnostic imaging*
;
Retrospective Studies
;
SARS-CoV-2/physiology*
;
Tomography, X-Ray Computed
;
Young Adult

Result Analysis
Print
Save
E-mail